Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations
Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thu...
Saved in:
Published in | Acta psychiatrica Scandinavica Vol. 136; no. 6; pp. 648 - 657 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.12.2017
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system.
Method
100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI‐to‐ROI and ROI‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects.
Results
LSD caused significant alterations in all dimensions of the 5D‐ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects.
Conclusion
Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐HT2A‐receptor in altered states of consciousness. |
---|---|
AbstractList | It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system.
100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI-to-ROI and ROI-to-voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects.
LSD caused significant alterations in all dimensions of the 5D-ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD-induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects.
Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5-HT
-receptor in altered states of consciousness. Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI ‐to‐ ROI and ROI ‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects. Results LSD caused significant alterations in all dimensions of the 5D‐ ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD ‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects. Conclusion Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐ HT 2A ‐receptor in altered states of consciousness. ObjectiveIt has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system.Method100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI‐to‐ROI and ROI‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects.ResultsLSD caused significant alterations in all dimensions of the 5D‐ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects.ConclusionHallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐HT2A‐receptor in altered states of consciousness. Objective It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates of consciousness. Hallucinogenic drugs such as LSD can be used to induce profoundly altered states of consciousness, and it is thus of interest to test the effects of these drugs on this system. Method 100 μg LSD was administrated orally to 20 healthy participants prior to fMRI assessment. Whole brain thalamic functional connectivity was measured using ROI‐to‐ROI and ROI‐to‐voxel approaches. Correlation analyses were used to explore relationships between thalamic connectivity to regions involved in auditory and visual hallucinations and subjective ratings on auditory and visual drug effects. Results LSD caused significant alterations in all dimensions of the 5D‐ASC scale and significantly increased thalamic functional connectivity to various cortical regions. Furthermore, LSD‐induced functional connectivity measures between the thalamus and the right fusiform gyrus and insula correlated significantly with subjective auditory and visual drug effects. Conclusion Hallucinogenic drug effects might be provoked by facilitations of cortical excitability via thalamocortical interactions. Our findings have implications for the understanding of the mechanism of action of hallucinogenic drugs and provide further insight into the role of the 5‐HT2A‐receptor in altered states of consciousness. |
Author | Müller, F. Lang, U. Dolder, P. Borgwardt, S. Schmidt, A. Liechti, M. Lenz, C. |
AuthorAffiliation | 1 Department of Psychiatry (UPK) University of Basel Basel Switzerland 2 Division of Clinical Pharmacology and Toxicology Department of Biomedicine and Department of Clinical Research University Hospital Basel University of Basel Basel Switzerland |
AuthorAffiliation_xml | – name: 2 Division of Clinical Pharmacology and Toxicology Department of Biomedicine and Department of Clinical Research University Hospital Basel University of Basel Basel Switzerland – name: 1 Department of Psychiatry (UPK) University of Basel Basel Switzerland |
Author_xml | – sequence: 1 givenname: F. surname: Müller fullname: Müller, F. organization: University of Basel – sequence: 2 givenname: C. surname: Lenz fullname: Lenz, C. organization: University of Basel – sequence: 3 givenname: P. surname: Dolder fullname: Dolder, P. organization: University of Basel – sequence: 4 givenname: U. surname: Lang fullname: Lang, U. organization: University of Basel – sequence: 5 givenname: A. surname: Schmidt fullname: Schmidt, A. organization: University of Basel – sequence: 6 givenname: M. surname: Liechti fullname: Liechti, M. organization: University of Basel – sequence: 7 givenname: S. orcidid: 0000-0002-5792-3987 surname: Borgwardt fullname: Borgwardt, S. email: stefan.borgwardt@upkbs.ch organization: University of Basel |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28940312$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kcFO3DAQhi0EYpctFx6gitQbUmCcxIl9qYQWWpBWohKt1JvrOJNdr7L21k4W7Y1H6DP2STAsIHqpL5bHn74ZzX9E9q2zSMgJhTMaz7nS63BGM075HhnTEiCFoqj2yRgAaFoK-DkiRyEs45NR4IdklHFRQE6zMfl1Y7VHFbBJ-oXq1MroxGPojZ3_ffgTetVjop21qHuzMf02USFRseIxabzZoE9cm8zuLiNsbDPo6ImabtDGqt44Gz6Qg1Z1AY9f7gn58eXq-_Q6nd1-vZlezFJdFJynbdbmudK05hqh4ioreZ6XDKBoWFuwvK5pBQiigVYwAZmqkGW0FlCCqivM8gn5vPOuh3qFjUbbe9XJtTcr5bfSKSP__bFmIeduI1kpeBU7TMinF4F3v4e4Arl0g7dxZklFCQxyYCJSpztKexeCx_atAwX5lIZ8SkM-pxHhj-9nekNf1x8BugPuTYfb_6jkxfTb3U76COYqmfc |
CitedBy_id | crossref_primary_10_1038_s41386_020_00906_2 crossref_primary_10_1016_j_bpsc_2022_04_003 crossref_primary_10_3389_fphar_2021_749068 crossref_primary_10_1016_j_pnpbp_2024_110951 crossref_primary_10_1016_j_neuropharm_2018_03_010 crossref_primary_10_1016_j_concog_2023_103536 crossref_primary_10_1016_j_nicl_2018_03_005 crossref_primary_10_1038_s41380_022_01721_5 crossref_primary_10_1038_s41398_023_02691_0 crossref_primary_10_1007_s40263_023_01008_5 crossref_primary_10_1007_s00702_024_02757_3 crossref_primary_10_1016_j_bpsc_2023_07_010 crossref_primary_10_1038_s41386_023_01574_8 crossref_primary_10_1093_braincomms_fcac329 crossref_primary_10_1016_j_encep_2024_02_007 crossref_primary_10_1016_j_neubiorev_2022_104689 crossref_primary_10_1016_j_neurot_2024_e00322 crossref_primary_10_1080_17512433_2018_1511424 crossref_primary_10_1021_acschemneuro_8b00043 crossref_primary_10_1124_pharmrev_120_000056 crossref_primary_10_1124_pr_118_017160 crossref_primary_10_1371_journal_pcbi_1010811 crossref_primary_10_1093_braincomms_fcae194 crossref_primary_10_1055_a_1721_2914 crossref_primary_10_3389_fphar_2018_00089 crossref_primary_10_3389_fpsyg_2022_1051478 crossref_primary_10_1016_j_neuroimage_2022_119434 crossref_primary_10_1038_s41598_023_44153_z crossref_primary_10_3390_biology12111380 crossref_primary_10_3389_fnins_2018_00007 crossref_primary_10_3389_fpsyt_2021_706017 crossref_primary_10_3389_fpsyt_2024_1386321 crossref_primary_10_1038_npp_2017_86 crossref_primary_10_1111_bcp_13918 crossref_primary_10_1016_j_euroneuro_2024_04_011 crossref_primary_10_1007_s00213_018_5055_9 crossref_primary_10_1523_JNEUROSCI_1659_20_2020 crossref_primary_10_1038_s41593_022_01177_4 crossref_primary_10_3389_fphar_2018_00208 crossref_primary_10_1016_j_drudis_2023_103804 crossref_primary_10_1038_s41583_020_0367_2 crossref_primary_10_1176_appi_ajp_2019_19010035 crossref_primary_10_1126_sciadv_abl6989 crossref_primary_10_1016_j_bpsc_2019_12_007 crossref_primary_10_1038_s41386_022_01479_y crossref_primary_10_1038_s44220_023_00133_w crossref_primary_10_1124_pharmrev_121_000514 crossref_primary_10_1038_s41597_022_01822_4 crossref_primary_10_1038_s41386_023_01588_2 crossref_primary_10_1080_02791072_2022_2125467 crossref_primary_10_1038_s41598_020_75019_3 crossref_primary_10_1176_appi_focus_19104 crossref_primary_10_1016_j_neubiorev_2022_104906 crossref_primary_10_1093_ijnp_pyab026 crossref_primary_10_1055_a_2261_0745 crossref_primary_10_1055_a_1981_3152 crossref_primary_10_1093_brain_awab406 crossref_primary_10_1521_pdps_2023_51_3_270 crossref_primary_10_1038_s41398_022_01846_9 crossref_primary_10_1016_j_biopsych_2019_05_019 crossref_primary_10_1016_j_nsa_2023_103929 crossref_primary_10_3389_fpsyg_2023_1100058 crossref_primary_10_3389_fnins_2023_1163600 crossref_primary_10_1124_pharmrev_121_000508 crossref_primary_10_1093_schbul_sbaa117 crossref_primary_10_1021_acschemneuro_8b00215 crossref_primary_10_1016_j_ejtd_2024_100431 crossref_primary_10_1016_j_euroneuro_2021_06_001 crossref_primary_10_1177_0269881121991569 crossref_primary_10_1016_j_neuroimage_2021_117809 crossref_primary_10_1016_j_nlm_2021_107467 crossref_primary_10_1016_j_tics_2023_01_003 crossref_primary_10_1073_pnas_1815129116 crossref_primary_10_1016_j_jcbs_2019_11_005 crossref_primary_10_3390_brainsci11111528 crossref_primary_10_1089_brain_2018_0633 crossref_primary_10_1371_journal_pone_0284271 crossref_primary_10_1097_ICU_0000000000000701 crossref_primary_10_3389_fphar_2021_711255 crossref_primary_10_1038_s41380_023_02360_0 crossref_primary_10_3174_ajnr_A8118 crossref_primary_10_1007_s00429_020_02143_1 crossref_primary_10_1016_j_neuroimage_2023_120414 crossref_primary_10_1016_j_biopsych_2022_10_021 crossref_primary_10_1177_13634615221119388 crossref_primary_10_7554_eLife_69320 crossref_primary_10_3389_fpsyg_2018_01475 crossref_primary_10_1007_s00213_022_06117_5 crossref_primary_10_1162_imag_a_00033 crossref_primary_10_1016_j_neuroimage_2019_116462 |
Cites_doi | 10.1016/S0893-133X(98)00089-X 10.1523/JNEUROSCI.20-23-08846.2000 10.1093/schbul/sbs117 10.1007/s00213-016-4453-0 10.1073/pnas.1518377113 10.1016/S0893-133X(96)00246-1 10.1111/jnc.13398 10.1212/WNL.0b013e31829d86cc 10.1016/j.neubiorev.2016.05.037 10.1126/science.282.5395.1846 10.1017/S0033291715002901 10.1016/S1053-8119(03)00103-4 10.1001/archgenpsychiatry.2010.116 10.1038/nrn3137 10.1016/j.neuropsychologia.2012.08.023 10.1016/j.cub.2016.12.030 10.1016/S0306-4522(01)00199-3 10.1523/JNEUROSCI.5778-12.2013 10.1124/pr.115.011478 10.1523/JNEUROSCI.2015-10.2010 10.1016/0306-4522(91)90075-Y 10.1016/j.concog.2011.01.007 10.1007/s00213-006-0358-7 10.1097/ALN.0b013e318277a801 10.3389/fnsys.2014.00083 10.1016/j.neuron.2012.09.033 10.1016/j.neuroimage.2015.04.027 10.1177/0269881114555249 10.3389/fnhum.2013.00084 10.1016/j.tips.2008.06.006 10.1016/S0140-6736(00)02271-6 10.1101/cshperspect.a009621 10.1038/npp.2016.82 10.1089/brain.2012.0073 10.1016/S0304-3940(03)00547-0 10.1006/ccog.1995.1003 10.1097/00001756-199812010-00024 10.1093/cercor/bht358 10.7554/eLife.05352 10.1098/rstb.1998.0336 10.1073/pnas.1119598109 10.1016/j.tics.2010.09.001 10.1007/s00429-015-1018-7 10.1016/j.neuroimage.2013.08.048 10.1016/j.neuron.2014.03.020 10.1016/j.neuron.2016.10.024 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P 10.1016/j.cub.2016.02.010 10.1055/s-2007-979352 10.7554/eLife.04499 10.1016/S2215-0366(16)30065-7 10.1371/journal.pone.0012412 10.1016/j.neuroimage.2012.06.036 10.1016/j.biopsych.2014.11.015 10.1016/S1053-8100(03)00017-5 |
ContentType | Journal Article |
Copyright | 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd. 2017 John Wiley & Sons A/S, Published by John Wiley & Sons Ltd |
Copyright_xml | – notice: 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd – notice: 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd. – notice: 2017 John Wiley & Sons A/S, Published by John Wiley & Sons Ltd |
DBID | 24P WIN CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK K9. 5PM |
DOI | 10.1111/acps.12818 |
DatabaseName | Wiley_OA刊 Wiley Unsubscribed Journals Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts |
DatabaseTitleList | MEDLINE CrossRef ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley_OA刊 url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Müller et al |
EISSN | 1600-0447 |
EndPage | 657 |
ExternalDocumentID | 10_1111_acps_12818 28940312 ACPS12818 |
Genre | article Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: Swiss National Science Foundation funderid: 320030_170249 – fundername: Swiss National Science Foundation grantid: 320030_170249 |
GroupedDBID | --- -~X .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OB 1OC 23M 24P 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFS ACGOF ACHQT ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EAD EAP EAS EBC EBD EBS EJD EMB EMK EMOBN EPS ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO L7B LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OHT OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UPT V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR X7M XG1 YF5 ZGI ZXP ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK K9. 5PM |
ID | FETCH-LOGICAL-c4488-f2f33ac1b8ce078a2683365004d5f453bb170e09d0f95902a7e521b9060ab7e23 |
IEDL.DBID | 24P |
ISSN | 0001-690X |
IngestDate | Tue Sep 17 21:24:59 EDT 2024 Thu Oct 10 20:25:28 EDT 2024 Fri Aug 23 03:25:18 EDT 2024 Sat Sep 28 08:27:12 EDT 2024 Sat Aug 24 00:53:10 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | psychedelics fMRI hallucinogens functional connectivity thalamus |
Language | English |
License | Attribution-NonCommercial 2017 The Authors Acta Psychiatrica Scandinavica Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4488-f2f33ac1b8ce078a2683365004d5f453bb170e09d0f95902a7e521b9060ab7e23 |
ORCID | 0000-0002-5792-3987 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Facps.12818 |
PMID | 28940312 |
PQID | 1960503059 |
PQPubID | 33508 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5698745 proquest_journals_1960503059 crossref_primary_10_1111_acps_12818 pubmed_primary_28940312 wiley_primary_10_1111_acps_12818_ACPS12818 |
PublicationCentury | 2000 |
PublicationDate | December 2017 |
PublicationDateYYYYMMDD | 2017-12-01 |
PublicationDate_xml | – month: 12 year: 2017 text: December 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Aalborg – name: Hoboken |
PublicationTitle | Acta psychiatrica Scandinavica |
PublicationTitleAlternate | Acta Psychiatr Scand |
PublicationYear | 2017 |
Publisher | Blackwell Publishing Ltd John Wiley and Sons Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: John Wiley and Sons Inc |
References | 2015; 78 1999; 409 2010; 14 2016; 221 2003; 19 1998; 353 2013; 7 2012; 13 2001; 105 2003; 12 2014; 3 1991; 44 2008; 29 2013; 118 2011; 20 2016; 234 2016; 113 2016; 41 1997; 16 2011; 68 2014; 8 2010; 5 2010; 30 2016; 46 1998; 282 2012; 63 2015; 19 2000; 355 2017; 27 2000; 20 2007 1999; 20 2016; 92 2014; 84 1995; 4 2014; 82 2012; 76 2012; 109 2012; 50 2015; 25 2012; 2 2013; 39 2015; 29 2016; 3 2013; 33 2015; 114 2006; 186 2013; 81 2016; 136 2003; 346 1998; 31 2016; 26 2016; 69 2016; 68 1998; 9 e_1_2_9_31_1 e_1_2_9_52_1 e_1_2_9_50_1 e_1_2_9_10_1 e_1_2_9_35_1 e_1_2_9_56_1 e_1_2_9_12_1 e_1_2_9_33_1 e_1_2_9_54_1 Dolder PC (e_1_2_9_29_1) 2015; 19 e_1_2_9_14_1 e_1_2_9_39_1 e_1_2_9_16_1 e_1_2_9_37_1 e_1_2_9_58_1 e_1_2_9_18_1 e_1_2_9_41_1 e_1_2_9_20_1 e_1_2_9_22_1 e_1_2_9_45_1 e_1_2_9_24_1 e_1_2_9_43_1 e_1_2_9_8_1 e_1_2_9_6_1 e_1_2_9_4_1 e_1_2_9_2_1 Jones E (e_1_2_9_40_1) 2007 e_1_2_9_26_1 e_1_2_9_49_1 e_1_2_9_28_1 e_1_2_9_47_1 e_1_2_9_30_1 e_1_2_9_53_1 e_1_2_9_51_1 e_1_2_9_11_1 e_1_2_9_34_1 e_1_2_9_57_1 e_1_2_9_13_1 e_1_2_9_32_1 e_1_2_9_55_1 e_1_2_9_15_1 e_1_2_9_38_1 e_1_2_9_17_1 e_1_2_9_36_1 e_1_2_9_19_1 e_1_2_9_42_1 e_1_2_9_21_1 e_1_2_9_46_1 e_1_2_9_23_1 e_1_2_9_44_1 e_1_2_9_7_1 e_1_2_9_5_1 e_1_2_9_3_1 e_1_2_9_9_1 e_1_2_9_25_1 e_1_2_9_27_1 e_1_2_9_48_1 |
References_xml | – volume: 12 start-page: 413 year: 2003 end-page: 51 article-title: Hallucinations: synchronisation of thalamocortical gamma oscillations underconstrained by sensory input publication-title: Conscious Cogn – volume: 92 start-page: 687 year: 2016 end-page: 704 article-title: Tapping the brakes: cellular and synaptic mechanisms that regulate thalamic oscillations publication-title: Neuron – volume: 25 start-page: 1618 year: 2015 end-page: 28 article-title: Human thalamus regulates cortical activity via spatially specific and structurally constrained phase‐amplitude coupling publication-title: Cereb Cortex – volume: 31 start-page: 85 issue: Suppl 2 year: 1998 end-page: 91 article-title: Blood flow and cerebral laterality in the mescaline model of psychosis publication-title: Pharmacopsychiatry – volume: 355 start-page: 1790 year: 2000 end-page: 1 article-title: Restoration of thalamocortical connectivity after recovery from persistent vegetative state publication-title: Lancet – volume: 3 start-page: 619 year: 2016 end-page: 27 article-title: Psilocybin with psychological support for treatment‐resistant depression: an open‐label feasibility study publication-title: Lancet Psychiatry – volume: 68 start-page: 71 year: 2011 end-page: 8 article-title: Pilot study of psilocybin treatment for anxiety in patients with advanced‐stage cancer publication-title: Arch Gen Psychiatry – volume: 50 start-page: 3519 year: 2012 end-page: 27 article-title: Memory signals from the thalamus: early thalamocortical phase synchronization entrains gamma oscillations during long‐term memory retrieval publication-title: Neuropsychologia – volume: 8 start-page: 83 year: 2014 article-title: Intralaminar and medial thalamic influence on cortical synchrony, information transmission and cognition publication-title: Front Syst Neurosci – volume: 2 start-page: 125 year: 2012 end-page: 41 article-title: Conn: a functional connectivity toolbox for correlated and anticorrelated brain networks publication-title: Brain Connectivity – volume: 113 start-page: 4853 year: 2016 end-page: 8 article-title: Neural correlates of the LSD experience revealed by multimodal neuroimaging publication-title: Proc Natl Acad Sci USA – volume: 7 start-page: 84 year: 2013 article-title: Cross‐frequency coupling within and between the human thalamus and neocortex publication-title: Front Human Neurosci – volume: 282 start-page: 1846 year: 1998 end-page: 51 article-title: Consciousness and complexity publication-title: Science – volume: 19 start-page: 402 year: 2003 end-page: 11 article-title: Impaired thalamocortical connectivity in humans during general‐anesthetic‐induced unconsciousness publication-title: NeuroImage – volume: 234 start-page: 1499 year: 2016 end-page: 1510 article-title: Alterations of consciousness and mystical‐type experiences after acute LSD in humans publication-title: Psychopharmacology – volume: 114 start-page: 448 year: 2015 end-page: 65 article-title: Comparison of functional thalamic segmentation from seed‐based analysis and ICA publication-title: NeuroImage – volume: 16 start-page: 357 year: 1997 end-page: 72 article-title: Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis publication-title: Neuropsychopharmacology – volume: 29 start-page: 445 year: 2008 end-page: 53 article-title: Serotonin research: contributions to understanding psychoses publication-title: Trends Pharmacol Sci – volume: 27 start-page: 451 year: 2017 end-page: 7 article-title: The fabric of meaning and subjective effects in LSD‐induced states depend on serotonin 2A receptor activation publication-title: Curr Biol – volume: 105 start-page: 379 year: 2001 end-page: 92 article-title: A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex publication-title: Neuroscience – volume: 221 start-page: 1971 year: 2016 end-page: 84 article-title: Functional topography of the thalamocortical system in human publication-title: Brain Struct Funct – volume: 9 start-page: 3897 year: 1998 end-page: 902 article-title: Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action publication-title: NeuroReport – volume: 78 start-page: 544 year: 2015 end-page: 53 article-title: Acute effects of lysergic acid diethylamide in healthy subjects publication-title: Biol Psychiatry – volume: 136 start-page: 526 year: 2016 end-page: 35 article-title: Modulation of GABA release from the thalamic reticular nucleus by cocaine and caffeine: role of serotonin receptors publication-title: J Neurochem – volume: 44 start-page: 521 year: 1991 end-page: 35 article-title: Of dreaming and wakefulness publication-title: Neuroscience – volume: 20 start-page: 8846 year: 2000 end-page: 52 article-title: DOI‐Induced activation of the cortex: dependence on 5‐HT2A heteroreceptors on thalamocortical glutamatergic neurons publication-title: J Neurosci – volume: 186 start-page: 93 year: 2006 end-page: 8 article-title: Increased frontal and paralimbic activation following ayahuasca, the pan‐Amazonian inebriant publication-title: Psychopharmacology – volume: 69 start-page: 113 year: 2016 end-page: 23 article-title: The neural mechanisms of hallucinations: A quantitative meta‐analysis of neuroimaging studies publication-title: Neurosci Biobehav Rev – volume: 33 start-page: 17827 year: 2013 end-page: 35 article-title: The phase of thalamic alpha activity modulates cortical gamma‐band activity: evidence from resting‐state MEG recordings publication-title: J Neurosci – volume: 26 start-page: 1043 year: 2016 end-page: 50 article-title: Increased global functional connectivity correlates with LSD‐induced ego dissolution publication-title: Curr Biol – volume: 409 start-page: 187 year: 1999 end-page: 209 article-title: Cellular and subcellular distribution of the serotonin 5‐HT2A receptor in the central nervous system of adult rat publication-title: J Comp Neurol – volume: 39 start-page: 1343 year: 2013 end-page: 51 article-title: Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis publication-title: Schizophr Bull – volume: 29 start-page: 57 year: 2015 end-page: 68 article-title: LSD‐assisted psychotherapy for anxiety associated with a life‐threatening disease: a qualitative study of acute and sustained subjective effects publication-title: J Psychopharmacol – volume: 19 start-page: 1 year: 2015 end-page: 7 article-title: Pharmacokinetics and concentration‐effect relationship of oral LSD in humans publication-title: Int J Neuropsychopharmacol – volume: 76 start-page: 1010 year: 2012 end-page: 20 article-title: Electrophysiological low‐frequency coherence and cross‐frequency coupling contribute to BOLD connectivity publication-title: Neuron – volume: 20 start-page: 565 year: 1999 end-page: 81 article-title: Neurometabolic effects of psilocybin, 3,4‐methylenedioxyethylamphetamine (MDE) and d‐methamphetamine in healthy volunteers. A double‐blind, placebo‐controlled PET study with [18F]FDG publication-title: Neuropsychopharmacology – volume: 20 start-page: 464 year: 2011 end-page: 86 article-title: The thalamic dynamic core theory of conscious experience publication-title: Conscious Cogn – volume: 81 start-page: 509 year: 2013 end-page: 10 article-title: From the thalamus with love: a rare window into the locus of emotional synesthesia publication-title: Neurology – year: 2007 – volume: 4 start-page: 52 year: 1995 end-page: 62 article-title: On the neurophysiology of consciousness: I. An overview publication-title: Conscious Cogn – volume: 118 start-page: 59 year: 2013 end-page: 69 article-title: Differential effects of deep sedation with propofol on the specific and nonspecific thalamocortical systems: a functional magnetic resonance imaging study publication-title: Anesthesiology – volume: 41 start-page: 2638 year: 2016 end-page: 46 article-title: LSD acutely impairs fear recognition and enhances emotional empathy and sociality publication-title: Neuropsychopharmacology – volume: 30 start-page: 11379 year: 2010 end-page: 87 article-title: Development of a large‐scale functional brain network during human non‐rapid eye movement sleep publication-title: J Neurosci – volume: 3 start-page: e05352 year: 2014 article-title: Corticothalamic phase synchrony and cross‐frequency coupling predict human memory formation publication-title: eLife – volume: 2 start-page: a009621 year: 2012 article-title: Functional neuroanatomy of the basal ganglia publication-title: Cold Spring Harb Perspect Med – volume: 5 start-page: e12412 year: 2010 article-title: Psychometric evaluation of the altered states of consciousness rating scale (OAV) publication-title: PLoS ONE – volume: 14 start-page: 506 year: 2010 end-page: 15 article-title: The functional role of cross‐frequency coupling publication-title: Trends Cogn Sci – volume: 353 start-page: 1841 year: 1998 end-page: 9 article-title: The neuronal basis for consciousness publication-title: Philos Trans R Soc Lond B Biol Sci – volume: 13 start-page: 121 year: 2012 end-page: 34 article-title: Spectral fingerprints of large‐scale neuronal interactions publication-title: Nat Rev Neurosci – volume: 68 start-page: 264 year: 2016 end-page: 355 article-title: Psychedelics publication-title: Pharmacol Rev – volume: 3 start-page: e04499 year: 2014 article-title: Disruption of thalamic functional connectivity is a neural correlate of dexmedetomidine‐induced unconsciousness publication-title: eLife – volume: 346 start-page: 137 year: 2003 end-page: 40 article-title: The hallucinogen 1‐[2,5‐dimethoxy‐4‐iodophenyl]‐2‐aminopropane (DOI) increases cortical extracellular glutamate levels in rats publication-title: Neurosci Lett – volume: 63 start-page: 63 year: 2012 end-page: 72 article-title: Automatic sleep staging using fMRI functional connectivity data publication-title: NeuroImage – volume: 46 start-page: 1379 year: 2016 end-page: 1390 article-title: The paradoxical psychological effects of lysergic acid diethylamide (LSD) publication-title: Psychol Med – volume: 84 start-page: 320 year: 2014 end-page: 41 article-title: Methods to detect, characterize, and remove motion artifact in resting state fMRI publication-title: NeuroImage – volume: 109 start-page: 2138 year: 2012 end-page: 43 article-title: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin publication-title: Proc Natl Acad Sci USA – volume: 82 start-page: 695 year: 2014 end-page: 708 article-title: Decoding wakefulness levels from typical fMRI resting‐state data reveals reliable drifts between wakefulness and sleep publication-title: Neuron – ident: e_1_2_9_11_1 doi: 10.1016/S0893-133X(98)00089-X – ident: e_1_2_9_16_1 doi: 10.1523/JNEUROSCI.20-23-08846.2000 – ident: e_1_2_9_19_1 doi: 10.1093/schbul/sbs117 – ident: e_1_2_9_37_1 doi: 10.1007/s00213-016-4453-0 – ident: e_1_2_9_39_1 doi: 10.1073/pnas.1518377113 – ident: e_1_2_9_13_1 doi: 10.1016/S0893-133X(96)00246-1 – ident: e_1_2_9_56_1 doi: 10.1111/jnc.13398 – ident: e_1_2_9_53_1 doi: 10.1212/WNL.0b013e31829d86cc – ident: e_1_2_9_33_1 doi: 10.1016/j.neubiorev.2016.05.037 – ident: e_1_2_9_28_1 doi: 10.1126/science.282.5395.1846 – ident: e_1_2_9_3_1 doi: 10.1017/S0033291715002901 – ident: e_1_2_9_26_1 doi: 10.1016/S1053-8119(03)00103-4 – ident: e_1_2_9_4_1 doi: 10.1001/archgenpsychiatry.2010.116 – ident: e_1_2_9_51_1 doi: 10.1038/nrn3137 – ident: e_1_2_9_50_1 doi: 10.1016/j.neuropsychologia.2012.08.023 – ident: e_1_2_9_15_1 doi: 10.1016/j.cub.2016.12.030 – ident: e_1_2_9_18_1 doi: 10.1016/S0306-4522(01)00199-3 – ident: e_1_2_9_47_1 doi: 10.1523/JNEUROSCI.5778-12.2013 – ident: e_1_2_9_8_1 doi: 10.1124/pr.115.011478 – ident: e_1_2_9_34_1 doi: 10.1523/JNEUROSCI.2015-10.2010 – ident: e_1_2_9_54_1 doi: 10.1016/0306-4522(91)90075-Y – ident: e_1_2_9_23_1 doi: 10.1016/j.concog.2011.01.007 – ident: e_1_2_9_38_1 doi: 10.1007/s00213-006-0358-7 – ident: e_1_2_9_25_1 doi: 10.1097/ALN.0b013e318277a801 – ident: e_1_2_9_41_1 doi: 10.3389/fnsys.2014.00083 – ident: e_1_2_9_44_1 doi: 10.1016/j.neuron.2012.09.033 – ident: e_1_2_9_42_1 doi: 10.1016/j.neuroimage.2015.04.027 – ident: e_1_2_9_5_1 doi: 10.1177/0269881114555249 – ident: e_1_2_9_46_1 doi: 10.3389/fnhum.2013.00084 – ident: e_1_2_9_9_1 doi: 10.1016/j.tips.2008.06.006 – ident: e_1_2_9_22_1 doi: 10.1016/S0140-6736(00)02271-6 – volume-title: The Thalamus year: 2007 ident: e_1_2_9_40_1 contributor: fullname: Jones E – volume: 19 start-page: 1 year: 2015 ident: e_1_2_9_29_1 article-title: Pharmacokinetics and concentration‐effect relationship of oral LSD in humans publication-title: Int J Neuropsychopharmacol contributor: fullname: Dolder PC – ident: e_1_2_9_58_1 doi: 10.1101/cshperspect.a009621 – ident: e_1_2_9_7_1 doi: 10.1038/npp.2016.82 – ident: e_1_2_9_31_1 doi: 10.1089/brain.2012.0073 – ident: e_1_2_9_17_1 doi: 10.1016/S0304-3940(03)00547-0 – ident: e_1_2_9_21_1 doi: 10.1006/ccog.1995.1003 – ident: e_1_2_9_14_1 doi: 10.1097/00001756-199812010-00024 – ident: e_1_2_9_48_1 doi: 10.1093/cercor/bht358 – ident: e_1_2_9_49_1 doi: 10.7554/eLife.05352 – ident: e_1_2_9_27_1 doi: 10.1098/rstb.1998.0336 – ident: e_1_2_9_12_1 doi: 10.1073/pnas.1119598109 – ident: e_1_2_9_45_1 doi: 10.1016/j.tics.2010.09.001 – ident: e_1_2_9_43_1 doi: 10.1007/s00429-015-1018-7 – ident: e_1_2_9_32_1 doi: 10.1016/j.neuroimage.2013.08.048 – ident: e_1_2_9_35_1 doi: 10.1016/j.neuron.2014.03.020 – ident: e_1_2_9_57_1 doi: 10.1016/j.neuron.2016.10.024 – ident: e_1_2_9_55_1 doi: 10.1002/(SICI)1096-9861(19990628)409:2<187::AID-CNE2>3.0.CO;2-P – ident: e_1_2_9_20_1 doi: 10.1016/j.cub.2016.02.010 – ident: e_1_2_9_10_1 doi: 10.1055/s-2007-979352 – ident: e_1_2_9_24_1 doi: 10.7554/eLife.04499 – ident: e_1_2_9_6_1 doi: 10.1016/S2215-0366(16)30065-7 – ident: e_1_2_9_30_1 doi: 10.1371/journal.pone.0012412 – ident: e_1_2_9_36_1 doi: 10.1016/j.neuroimage.2012.06.036 – ident: e_1_2_9_2_1 doi: 10.1016/j.biopsych.2014.11.015 – ident: e_1_2_9_52_1 doi: 10.1016/S1053-8100(03)00017-5 |
SSID | ssj0005108 |
Score | 2.554763 |
Snippet | Objective
It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural... It has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural correlates... ObjectiveIt has been proposed that the thalamocortical system is an important site of action of hallucinogenic drugs and an essential component of the neural... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 648 |
SubjectTerms | Brain mapping Cerebral cortex Consciousness Cross-Over Studies Double-Blind Method Excitability fMRI functional connectivity Functional magnetic resonance imaging Hallucinations Hallucinations - chemically induced hallucinogens Humans LSD Lysergic acid diethylamide Lysergic Acid Diethylamide - pharmacology Lysergide Magnetic Resonance Imaging Neural networks Original psychedelics Rest Sensory integration Serotonin S2 receptors Thalamus Thalamus - diagnostic imaging Thalamus - drug effects Thalamus - physiopathology |
Title | Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Facps.12818 https://www.ncbi.nlm.nih.gov/pubmed/28940312 https://www.proquest.com/docview/1960503059 https://pubmed.ncbi.nlm.nih.gov/PMC5698745 |
Volume | 136 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QHwRb-tFQJ-EStr0CvgiHoioLB6wbzVJE1aQKu767k_wN_pLnEm76y6C4EspNA1lpnMlX74B2JdpkqlIu1ALlYVJYfJQYiQPTVxEkZU2z_zSwPVNdvGQXHbT7hQcDc_CNPwQowU3sgzvr8nAle6PGbkyr_1D2gcqpmGWKGOIOT9OOj8Aj4g3fhgLZqwBuy05KeF4ft6dDEe_cszfUMnxFNbHoPNFWGiTR3bcaHsJpmy9DHPX7fb4CjyitRPI3FZs0FPP1GqeUe8NDE9fH5_-7BAzhGwxTc8IpvpMMSKyZNUbATTYi2NXd6c4GEt1VHrFqNfKO87eLOytwsP52f3JRdi2UAgN1l1F6GInhDKRLozFZEDFWSEEJmU8qVKXpELrKOeWy4o7SUQuKrcYz7XkGVc6t7FYg5n6pbYbwLjmyhmnhM11oqNUob1agdHdFSmvTB7A3lCS5WvDlFEOKwySd-nlHcD2UMhlay34BMuolDyPDGC9kfdoCiwIE3Q8cQD5hCZGA4gfe_JJ_dTzPNlpJonMP4ADr7M_vqo8Punc-bvN_wzegvmYorxHt2zDzODt3e5gjjLQu_5XxOvpbfwNM1Hljw |
link.rule.ids | 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB6VRSpcChQoaSlYoqdKWTlxnkfEQ1vYRYiHtLdgO7ZAVAHt49ITP4Hf2F_SGSe7sEVCglskO1bi8Yy_GY-_AfiRx1EiA2V9JWTiR5lO_Rx3cl-HWRCY3KSJCw30TpLOZXTUj_tNbg7dhan5IaYBN9IMZ69JwSkg_UzLpb4ftukgKJuDedR3QZUb9s-e2KNwudWGGD1mdAL7DTspJfI8vTu7H70AmS9zJZ9jWLcJHS7VlVaHjruQck9u2-ORaus__zE7vvv_luFTA0_Zbr2eVuCDqT7Dx15zAL8KV2hPKI3dlGx0LX9TMXtG1T1wA_z78OhuJzFNuTO6rkrB5JBJRlSZrBxQCgi7s6x7vo-db6oSl1XJqJrLGEevQ4drcHl4cLHX8ZsiDb5Gzy7zbWiFkDpQmTYIN2SYZEIg7ONRGdsoFkoFKTc8L7nNiSpGpgYRg8p5wqVKTSjWoVXdVWYDGFdcWm2lMKmKVBBLtAhGIH6wWcxLnXqwMxFVcV9zcRQTH4Ymq3CT5cHmRIpFo4_Ygo5aTLYt9-BLLdDpEOhyRmjaQg_SGVFPOxAD92xLdXPtmLjjJKdyAR78dJJ85auK3b3Tc_f09S2dt2Ghc9HrFt1fJ8ffYDEkTOFyaTahNRqMzXdERCO15db9PzOkCUE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ZS8QwEB48QHwRb-sZ0CehkjbpBb6IunizoMK-1SRNWEHWRdd3f4K_0V_iTNpdXQTBt0LSUGY6x5dMvgHYKxKZqki7UAuVhjI3WVhgJA9NnEeRLWyW-q2B65v07F5edJLOBBwO78LU_BCjDTeyDO-vycD7lfth5Mr0Xw_oHCifhGmJeTgx58ey_V3gEfHaDyNgRgzYachJqY7n-93xcPQrx_xdKvkzhfUxqDUPc03yyI5qbS_AhO0twsx1czy-BA9o7VRkbis26KonajXPqPcGhqfP9w9_d4gZqmwxdc8Ipl6ZYkRkyaoXKtBgz45d3Z7gZITqqPSKUa-VN1y93thbhvvW6d3xWdi0UAgN4q48dLETQplI58ZiMqDiNBcCkzIuq8TJRGgdZdzyouKuICIXlVmM57rgKVc6s7FYganec8-uAeOaK2ecEjbTUkeJQnu1AqO7yxNemSyA3aEky37NlFEOEQbJu_TyDmBzKOSysRYcQRiVkOcpAlit5T1aAgGhRMcTB5CNaWI0gfixx0d6j13Pk52kBZH5B7DvdfbHV5VHx-1b_7T-n8k7MNM-aZVX5zeXGzAbU8D3hS6bMDV4ebNbmK4M9Lb_K78A0uDnOg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+thalamic+resting%E2%80%90state+connectivity+as+a+core+driver+of+LSD%E2%80%90induced+hallucinations&rft.jtitle=Acta+psychiatrica+Scandinavica&rft.au=M%C3%BCller%2C+F.&rft.au=Lenz%2C+C.&rft.au=Dolder%2C+P.&rft.au=Lang%2C+U.&rft.date=2017-12-01&rft.issn=0001-690X&rft.eissn=1600-0447&rft.volume=136&rft.issue=6&rft.spage=648&rft.epage=657&rft_id=info:doi/10.1111%2Facps.12818&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_acps_12818 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-690X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-690X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-690X&client=summon |